Crux Biomedical , a company founded by Dr. Thomas Fogarty, the famous medical device inventor and noted winegrower, has reported highly positive results from a clinical trial of the Crux Vena Cava Filter (VCF) System in preventing recurrent pulmonary embolisms. The new device, which is cleared for use in Europe and is under an Investigational Device Exemption (IDE) in the U.S., was designed by Fogarty and team to prevent known complications from existing devices like penetration of the caval wall, damage to nearby organs, and tilting of the filter that may allow emboli to pass. Read More Read More...